New Butin Sustained-release Tablet (Trimebutine Maleate)

Adult dose

Take 1 tablet twice a day on an empty stomach

This medication should be used with caution as its safety has not been sufficiently established during the first three months of pregnancy or while breastfeeding. It is advisable to avoid taking this medication if pregnant or breastfeeding. Rarely, fatigue, fever, or chills may occur when taking this medication. Additionally, gastrointestinal symptoms such as mild diarrhea, nausea, vomiting, constipation, and dyspepsia may occur. Some drowsiness or mild dizziness may also be experienced, so caution is advised when driving or operating machinery.

Mild side effects

• Fatigue
• fever
• chills
• mild diarrhea
• nausea
• vomiting
• constipation
• gastrointestinal disturbances
• slight sedation
• mild dizziness

This medication should be stored in a tightly sealed container to protect it from air and moisture and is best stored at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness and prevent degradation.

Appearance

White rectangular sustained-release film-coated tablet

Package unit

For domestic use - 100 tablets/bottle, For domestic use - 30 tablets/bottle, For export - 30 tablets/bottle, For export - 30 tablets/box [(10 tablets/PTPX3)]